Elisa Rossi Selected Research

Elisa Rossi Research Topics

Disease

20	Neoplasms (Cancer) 07/2015 - 06/2003
8	Hereditary Hemorrhagic Telangiectasia 01/2023 - 01/2012
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2009 - 07/2003
7	Carcinoma (Carcinomatosis) 07/2013 - 06/2006
4	Adenocarcinoma 12/2012 - 03/2008
3	COVID-19 08/2023 - 01/2021
3	Vascular Diseases (Vascular Disease) 01/2022 - 01/2018
3	Hemorrhage 01/2022 - 02/2009
3	Inflammation (Inflammations) 08/2021 - 01/2013
3	Heart Failure 09/2020 - 06/2003
3	Neoplasm Metastasis (Metastasis) 06/2007 - 11/2006
3	Ovarian Neoplasms (Ovarian Cancer) 06/2007 - 11/2006
2	Ischemia 10/2023 - 10/2017
2	Lung Diseases (Lung Disease) 08/2023 - 08/2005
2	Pre-Eclampsia (Preeclampsia) 01/2023 - 04/2016
2	Thrombosis (Thrombus) 01/2023 - 01/2023
2	Epistaxis (Nosebleed) 01/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 11/2020
2	Telangiectasis (Telangiectasia) 01/2019 - 01/2018
2	Acute Coronary Syndrome 09/2014 - 08/2013
2	Celiac Disease (Celiac Sprue) 06/2013 - 08/2011
2	Ovarian Epithelial Carcinoma 07/2009 - 06/2007
2	Disease Progression 08/2004 - 07/2003
1	Cerebral Palsy (Spastic Diplegia) 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Jaundice (Icterus) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Breakthrough Infections 01/2022
1	Rupture 01/2022
1	Aortic Valve Disease 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2019
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2018
1	Hypothyroidism 08/2017
1	Heart Diseases (Heart Disease) 03/2017
1	Pulmonary Hypertension 10/2015
1	Hemangioma (Angioma) 07/2015
1	Lung Neoplasms (Lung Cancer) 11/2014

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
12	EndoglinIBA 01/2023 - 01/2012
10	ErbB Receptors (EGF Receptor)IBA 09/2013 - 07/2003
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
6	IntegrinsIBA 01/2023 - 03/2007
6	Tyrosine Kinase InhibitorsIBA 11/2014 - 08/2004
6	Gefitinib (Iressa)FDA Link 04/2009 - 07/2003
3	Oxygen (Dioxygen)IBA 08/2023 - 06/2003
3	Mammaglobin BIBA 07/2013 - 06/2007
2	Fibrinogen (Factor I)FDA Link 01/2023 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 05/2005
2	ParaffinIBA 07/2013 - 06/2007
2	Messenger RNA (mRNA)IBA 07/2013 - 07/2009
2	UteroglobinIBA 07/2013 - 06/2007
2	TransglutaminasesIBA 06/2013 - 08/2011
2	ChemokinesIBA 01/2013 - 03/2007
2	Epidermal Growth Factor (EGF)IBA 12/2008 - 05/2005
2	OligonucleotidesIBA 03/2007 - 11/2006
2	1-oleoyl-2-stearoylphosphatidylcholineIBA 03/2007 - 11/2006
2	Heparin (Liquaemin)FDA LinkGeneric 03/2007 - 06/2003
1	NestinIBA 10/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Angiopoietin-2IBA 01/2022
1	Activin Receptors (Activin Receptor)IBA 01/2022
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2022
1	GonadotropinsIBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Thrombin FDA Link 01/2022
1	CalponinsIBA 01/2022
1	Angiopoietin-1IBA 01/2022
1	ProlactinIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2022
1	Actin Depolymerizing Factors (Cofilins)IBA 08/2021
1	CreatinineIBA 10/2020
1	LipidsIBA 10/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2017
1	MicroRNAs (MicroRNA)IBA 03/2017
1	HMGB1 Protein (HMG1)IBA 03/2017
1	Edetic Acid (EDTA)FDA Link 03/2017
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2015
1	Vasodilator Agents (Vasodilators)IBA 10/2015
1	matrigelIBA 07/2015
1	PAR-1-activating peptideIBA 07/2015
1	AfatinibIBA 11/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2014

Therapy/Procedure

8	Therapeutics 08/2023 - 08/2004
1	Length of Stay 01/2023
1	Rewarming 01/2023
1	Noninvasive Ventilation 01/2021
1	Artificial Heart (Artificial Hearts) 09/2020